Edition:
United Kingdom

Qiagen NV (QIA.DE)

QIA.DE on Xetra

34.20EUR
4:35pm GMT
Change (% chg)

€0.15 (+0.44%)
Prev Close
€34.05
Open
€33.99
Day's High
€34.34
Day's Low
€33.99
Volume
501,259
Avg. Vol
565,382
52-wk High
€34.34
52-wk Low
€25.22

Latest Key Developments (Source: Significant Developments)

Qiagen Partners With Ares Genetics, A Subsidiary Of Curetis N.V.
Monday, 18 Feb 2019 

Feb 18 (Reuters) - Qiagen NV ::QIAGEN PARTNERS WITH ARES GENETICS TO ADVANCE GLOBAL FIGHT AGAINST ANTIBIOTIC-RESISTANT PATHOGENS.QIAGEN NV - BROAD AGREEMENT WITH ARES GENETICS, A SUBSIDIARY OF CURETIS N.V..QIAGEN NV - ACQUIRED AN EXCLUSIVE LICENSE TO LEVERAGE ARES GENETICS' PROPRIETARY ANTIMICROBIAL RESISTANCE DATABASE.QIAGEN NV - OBTAINED NON-EXCLUSIVE WORLDWIDE LICENSE TO DEVELOP, COMMERCIALIZE MOLECULAR RESEARCH ASSAYS USING ARESDB CONTENT.QIAGEN NV - FINANCIAL DETAILS OF PARTNERSHIP WERE NOT DISCLOSED.  Full Article

Qiagen Reports Q4 EPS Of $0.26
Monday, 4 Feb 2019 

Feb 4 (Reuters) - Qiagen NV ::QTRLY NET SALES OF $403.2 MILLION.QTRLY EPS OF $0.26.QTRLY ADJUSTED EPS $0.40.QIAGEN SETS 2019 OUTLOOK FOR FURTHER GROWTH IN NET SALES AND ADJUSTED EPS.SAYS IN 2019 NET SALES ARE EXPECTED TO GROW ABOUT 7-8% CER.Q4 REVENUE VIEW $408.6 MILLION -- REFINITIV IBES DATA.Q4 EARNINGS PER SHARE VIEW $0.40 -- REFINITIV IBES DATA.SAYS EXPECTS ADJUSTED DILUTED EPS OF ABOUT $1.45-1.47 CER PER SHARE FOR FULL-YEAR 2019.FY2018 REVENUE VIEW $1.51 BILLION -- REFINITIV IBES DATA.FY2018 EARNINGS PER SHARE VIEW $1.35 -- REFINITIV IBES DATA.QIAGEN - CURRENCY MOVEMENTS AGAINST THE U.S. DOLLAR ARE EXPECTED TO HAVE AN ADVERSE IMPACT ON RESULTS OF ABOUT ONE PERCENTAGE POINT ON FULL-YEAR 2019 NET SALES.QIAGEN - CURRENCY MOVEMENTS AGAINST THE U.S. DOLLAR ARE EXPECTED TO HAVE AN ADVERSE IMPACT OF ABOUT $0.01 ON ADJUSTED DILUTED EPS IN FY19.SAYS FOR THE FIRST QUARTER OF 2019, NET SALES ARE EXPECTED TO GROW ABOUT 5-6% CER.SAYS FOR Q1 2019 ADJUSTED DILUTED EPS IS EXPECTED TO BE ABOUT $0.26-0.27 CER.SAYS NET SALES GREW 2% TO $403.2 MILLION IN THE FOURTH QUARTER OF 2018 OVER THE YEAR-AGO PERIOD.  Full Article

Qiagen To Acquire U.S Formulatrix Digital PCR Program
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Qiagen NV ::QIAGEN UNVEILS PLANS FOR NEXT-GENERATION DIGITAL PCR SYSTEMS.WE PLAN FOR EXPANSION INTO APPLICATIONS FOR MOLECULAR DIAGNOSTICS.UNDER TERMS OF AGREEMENT, QIAGEN AGREED ON DECEMBER 31, 2018, TO ACQUIRE ALL ASSETS RELATED TO DIGITAL PCR PROGRAM OF FORMULATRIX, INC., FOR $125 MILLION IN CASH.AGREEMENT INCLUDES FUTURE MILESTONE PAYMENTS OF UP TO APPROXIMATELY $135 MILLION.  Full Article

Qiagen Qtrly Adjusted EPS $0.35
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Qiagen NV ::QIAGEN REPORTS RESULTS FOR THIRD QUARTER AND FIRST NINE MONTHS OF 2018.Q3 2018 RESULTS EXCEED TARGETS AS QIAGEN ON TRACK TO ACHIEVE 2018 GOALS.QTRLY EPS OF $0.26; ADJUSTED EPS $0.35.ON TRACK TO ACHIEVE 2018 GOALS.QTRLY NET SALES OF $377.9 MILLION +3.8% REPORTED.REAFFIRMS 2018 NET SALES OUTLOOK AND RAISES TARGET FOR ADJUSTED EPS.Q3 EARNINGS PER SHARE VIEW $0.33, REVENUE VIEW $380.6 MILLION -- THOMSON REUTERS I/B/E/S.RAISING 2018 TARGET FOR ADJUSTED EPS TO $1.33-1.34 CER PER SHARE.FY2018 EARNINGS PER SHARE VIEW $1.30 -- THOMSON REUTERS I/B/E/S.  Full Article

Qiagen reports quarterly Net Sales Of $377.2 Million
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Qiagen NV ::QTRLY NET SALES OF $377.2 MILLION (+8% ACTUAL, +6% AT CONSTANT EXCHANGE RATES, OR CER) VERSUS. 5-6% CER GUIDANCE.QTRLY EPS OF $0.16; ADJUSTED EPS $0.34.QTRLY OPERATING INCOME MARGIN OF 14% OF SALES; ADJUSTED OPERATING INCOME MARGIN RISES TO 27% OF NET SALES.NGS-RELATED SALES SET TO ACHIEVE 2018 TARGET FOR MORE THAN $140 MILLION.QIAGEN REAFFIRMS 2018 OUTLOOK FOR GROWTH IN NET SALES AND ADJUSTED EPS.  Full Article

HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work
Wednesday, 4 Apr 2018 

April 5 (Reuters) - HTG Molecular Diagnostics Inc :HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING.HTG MOLECULAR DIAGNOSTICS INC - QIAGEN HAS AGREED TO PAY COMPANY LOW, SINGLE-DIGIT MILLIONS OF DOLLARS IN DEVELOPMENT FEES FOR NEXT-PHASE ACTIVITIES.HTG- QIAGEN ALSO AGREED TO PAY CO MILESTONE UPTO AMOUNT IN LOW,SINGLE-DIGIT MLN OF DOLLARS ON ACHIEVEMENT OF SOME MILESTONES IN NEXT-PHASE ACTIVITIES.HTG MOLECULAR DIAGNOSTICS INC - THE NEXT-PHASE ACTIVITIES ARE EXPECTED TO BE COMPLETED IN Q2 OF 2018.  Full Article

Qiagen Q4 Loss Per Share $0.18 Including Items
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Qiagen Nv ::QIAGEN REPORTS RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017, ANNOUNCES STAT-DX ACQUISITION AND NEW $200 MILLION SHARE REPURCHASE.Q4 SALES ROSE 8 PERCENT TO $396.9 MILLION.Q4 LOSS PER SHARE $0.18 INCLUDING ITEMS.Q4 ADJUSTED EARNINGS PER SHARE $0.43.REAFFIRMS 2020 MID-TERM TARGETS.Q4 EARNINGS PER SHARE VIEW $0.40 -- THOMSON REUTERS I/B/E/S.FOR 2018, EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE TO BE APPROXIMATELY $1.38-$1.40 CER.FOR 2018, QIAGEN EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE EXPECTED TO BE REDUCED TO ABOUT $1.31-1.33 CER.ORGANIC GROWTH IN NET SALES IS EXPECTED TO BE ABOUT 6-7% CER FOR 2018.  Full Article

Qiagen Signs Agreement To Acquire Stat-Dx
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Qiagen Nv ::QIAGEN ENTERS INTO AGREEMENT TO ACQUIRE STAT-DX, PLANS TO LAUNCH A NEXT-GENERATION, FULLY INTEGRATED MULTIPLEX PLATFORM FOR SYNDROMIC DISEASE TESTING.QIAGEN NV - NEW SYSTEM LAUNCH PLANNED FOR H2 2018 WITH TWO CE-IVD MOLECULAR DIAGNOSTICS, U.S. LAUNCH PLANNED FOR 2019.  Full Article

Facebook Reports Qtrly Earnings Per Share $1.44
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Facebook Inc ::FACEBOOK REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.QTRLY EARNINGS PER SHARE $1.44.QTRLY TOTAL REVENUE $12,972 MILLION VERSUS $8,809 MILLION.DAUS WERE 1.40 BILLION ON AVERAGE FOR DECEMBER 2017, AN INCREASE OF 14% YEAR-OVER-YEAR‍​.MAUS WERE 2.13 BILLION AS OF DECEMBER 31, 2017, AN INCREASE OF 14% YEAR-OVER-YEAR.QTRLY ADVERTISING REVENUE $12,779 MILLION VERSUS $8,629 MILLION.HEADCOUNT WAS 25,105 AS OF DECEMBER 31, 2017, AN INCREASE OF 47% YEAR-OVER-YEAR‍​.QTRLY OPERATING MARGIN 57 PERCENT VERSUS 52 PERCENT.FACEBOOK - MADE CHANGES IN QUARTER THAT REDUCED TIME SPENT ON FACEBOOK BY ROUGHLY 50 MILLION HOURS EVERY DAY.AS A RESULT OF TAX LAW, PROVISION FOR INCOME TAXES INCREASED BY $2.27 BILLION,DILUTED EPS DECREASED BY $0.77 FOR Q4, FULL YEAR 2017‍​.FACEBOOK - MOBILE ADVERTISING REVENUE REPRESENTED ABOUT 89% OF ADVERTISING REVENUE FOR Q4 2017, UP FROM ABOUT 84% OF ADVERTISING REVENUE IN Q4 2016.Q4 EARNINGS PER SHARE VIEW $1.95, REVENUE VIEW $12.55 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Qiagen to exceed $140 mln of NGS-related sales In 2018
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍GOAL SET TO EXCEED $140 MILLION OF NGS-RELATED SALES IN 2018, UP FROM OVER $115 MILLION IN 2017​.  Full Article

German stocks - Factors to watch on Feb. 19

BERLIN/FRANKFURT, Feb 19 The following are some of the factors that may move German stocks on Tuesday: